Artículos por temáticas

Cerebrovascular function during cognition in Parkinson's disease: A functional transcranial Doppler sonography study

Gutteridge DS, Saredakis D, Badcock NA, Collins-Praino LE, Keage HAD.

J Neurol Sci. 2020 Jan 15;408:116578. doi: 10.1016/j.jns.2019.116578. Epub 2019 Nov 11.

Multivariate Analysis of Joint Motion Data by Kinect: Application to Parkinson's Disease

Ren P, Bosch Bayard JF, Dong L, Chen J, Mao L, Ma D, Sanchez MA, Morejon DM, Bringas ML, Yao D, Jahanshahi M, Valdes-Sosa PA.

IEEE Trans Neural Syst Rehabil Eng. 2020 Jan;28(1):181-190. doi: 10.1109/TNSRE.2019.2953707. Epub 2019 Nov 15.

Regular Aerobic Exercise-Alleviated Dysregulation of CAMKIIα Carbonylation to Mitigate Parkinsonism via Homeostasis of Apoptosis With Autophagy

Liu W, Fu R, Wang Z, Liu S, Tang C, Li L, Yin D.

J Neuropathol Exp Neurol. 2020 Jan 1;79(1):46-61. doi: 10.1093/jnen/nlz106.

Activation of the Unfolded Protein Response and Proteostasis Disturbance in Parkinsonism-Dementia of Guam

Verheijen BM, Lussier C, Müller-Hübers C, Garruto RM, Oyanagi K, Braun RJ, van Leeuwen FW.

J Neuropathol Exp Neurol. 2020 Jan 1;79(1):34-45. doi: 10.1093/jnen/nlz110.

Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson's disease therapeutics

Moschovou K, Melagraki G, Mavromoustakos T, Zacharia LC, Afantitis A.

Expert Opin Drug Discov. 2020 Jan;15(1):53-62. doi: 10.1080/17460441.2020.1691165. Epub 2019 Nov 20.

Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis

Baiano C, Barone P, Trojano L, Santangelo G.

Mov Disord. 2020 Jan;35(1):45-54. doi: 10.1002/mds.27902. Epub 2019 Nov 19.

The noradrenergic system is necessary for survival of vulnerable midbrain dopaminergic neurons: implications for development and Parkinson's disease

Hassani OK, Rymar VV, Nguyen KQ, Huo L, Cloutier JF, Miller FD, Sadikot AF.

Neurobiol Aging. 2020 Jan;85:22-37. doi: 10.1016/j.neurobiolaging.2019.09.014. Epub 2019 Sep 30.

Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis

Dong B, Wu R.

Clin Neurol Neurosurg. 2020 Jan;188:105587. doi: 10.1016/j.clineuro.2019.105587. Epub 2019 Nov 4.

Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings

Katayama T, Sawada J, Kikuchi-Takeguchi S, Kano K, Takahashi K, Saito T, Okizaki A, Hasebe N.

Neurosci Lett. 2020 Jan 10;715:134564. doi: 10.1016/j.neulet.2019.134564. Epub 2019 Nov 13.

Bioluminescence Imaging of Neuroinflammation in a Mouse Model of Parkinson's Disease

Bernis ME, Tamgüney G.

Methods Mol Biol. 2020;2081:147-159. doi: 10.1007/978-1-4939-9940-8_10.

A mitochondrial uncoupler prodrug protects dopaminergic neurons and improves functional outcome in a mouse model of Parkinson's disease

Kishimoto Y, Johnson J, Fang W, Halpern J, Marosi K, Liu D, Geisler JG, Mattson MP.

Neurobiol Aging. 2020 Jan;85:123-130. doi: 10.1016/j.neurobiolaging.2019.09.011. Epub 2019 Sep 26.

Application of Reinforcement Learning to Deep Brain Stimulation in a Computational Model of Parkinson's Disease

Lu M, Wei X, Che Y, Wang J, Loparo KA.

IEEE Trans Neural Syst Rehabil Eng. 2020 Jan;28(1):339-349. doi: 10.1109/TNSRE.2019.2952637. Epub 2019 Nov 11.

VGF peptides as novel biomarkers in Parkinson's disease

Cocco C, Corda G, Lisci C, Noli B, Carta M, Brancia C, Manca E, Masala C, Marrosu F, Solla P, Manconi B, Bongioanni P, Ferri GL.

Cell Tissue Res. 2020 Jan;379(1):93-107. doi: 10.1007/s00441-019-03128-1. Epub 2019 Nov 12.

Ultrahigh-Performance Liquid Chromatography-High-Resolution Mass Spectrometry Metabolomics and Lipidomics Study of Stool from Transgenic Parkinson's Disease Mice Following Immunotherapy

Gill EL, Koelmel JP, Meke L, Yost RA, Garrett TJ, Okun MS, Flores C, Vedam-Mai V.

J Proteome Res. 2020 Jan 3;19(1):424-431. doi: 10.1021/acs.jproteome.9b00605. Epub 2019 Nov 22.

Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model

Oliveira LM, Henrique E, Bustelli IB, Netto NFC, Moreira TS, Takakura AC, Caetano AL.

Exp Neurol. 2020 Jan;323:113110. doi: 10.1016/j.expneurol.2019.113110. Epub 2019 Nov 8.